Case characteristics (n = 72) by no or marginal expression (− or +/−), positive expression (+), or strong positive expression (++ or +++) of AdipoR1 and R2 by immunohistochemistry
| . | Immunohistochemistry expression signal . | . | . | P . | ||||
|---|---|---|---|---|---|---|---|---|
| . | Negative or marginal . | Positive . | Strongly positive . | . | ||||
| AdipoR1 | ||||||||
| n (%) | 13 (17) | 37 (49) | 20 (26) | |||||
| Age, y (mean ± SD) | 67.4 ± 4.0 | 65.8 ± 7.8 | 67.1 ± 7.5 | 0.79 | ||||
| Gleason score, n (%) | 0.07 | |||||||
| Low or intermediate grade (2-7) | 10 (30) | 16 (49) | 7 (21) | |||||
| High grade (8-10) | 2 (8) | 15 (63) | 10 (37) | |||||
| Stage, n (%) | 0.64 | |||||||
| I and II | 6 (24) | 13 (52) | 6 (24) | |||||
| III and IV | 7 (16) | 36 (52) | 14 (32) | |||||
| PSA (median ± SE) | 10.1 ± 4.5 | 15.3 ± 7.6 | 14.5 ± 7.1 | 0.20 | ||||
| AdipoR2 | ||||||||
| n (%) | 15 (21) | 31 (43) | 26 (36) | |||||
| Age, y (mean ± SD) | 64.9 ± 5.7 | 67.3 ± 6.4 | 67.0 ± 6.9 | 0.80 | ||||
| Gleason score, n (%) | 0.22 | |||||||
| Low or intermediate grade (2-7) | 8 (22) | 15 (43) | 12 (34) | |||||
| High grade (8-10) | 2 (7) | 12 (44) | 13 (48) | |||||
| Stage, n (%) | 0.80 | |||||||
| I and II | 6 (21) | 13 (46) | 9 (32) | |||||
| III and IV | 9 (21) | 17 (40) | 17 (40) | |||||
| PSA (median ± SE) | 15.8 ± 4.8 | 12.1 ± 7.6 | 13.1 ± 5.3 | 0.31 | ||||
| . | Immunohistochemistry expression signal . | . | . | P . | ||||
|---|---|---|---|---|---|---|---|---|
| . | Negative or marginal . | Positive . | Strongly positive . | . | ||||
| AdipoR1 | ||||||||
| n (%) | 13 (17) | 37 (49) | 20 (26) | |||||
| Age, y (mean ± SD) | 67.4 ± 4.0 | 65.8 ± 7.8 | 67.1 ± 7.5 | 0.79 | ||||
| Gleason score, n (%) | 0.07 | |||||||
| Low or intermediate grade (2-7) | 10 (30) | 16 (49) | 7 (21) | |||||
| High grade (8-10) | 2 (8) | 15 (63) | 10 (37) | |||||
| Stage, n (%) | 0.64 | |||||||
| I and II | 6 (24) | 13 (52) | 6 (24) | |||||
| III and IV | 7 (16) | 36 (52) | 14 (32) | |||||
| PSA (median ± SE) | 10.1 ± 4.5 | 15.3 ± 7.6 | 14.5 ± 7.1 | 0.20 | ||||
| AdipoR2 | ||||||||
| n (%) | 15 (21) | 31 (43) | 26 (36) | |||||
| Age, y (mean ± SD) | 64.9 ± 5.7 | 67.3 ± 6.4 | 67.0 ± 6.9 | 0.80 | ||||
| Gleason score, n (%) | 0.22 | |||||||
| Low or intermediate grade (2-7) | 8 (22) | 15 (43) | 12 (34) | |||||
| High grade (8-10) | 2 (7) | 12 (44) | 13 (48) | |||||
| Stage, n (%) | 0.80 | |||||||
| I and II | 6 (21) | 13 (46) | 9 (32) | |||||
| III and IV | 9 (21) | 17 (40) | 17 (40) | |||||
| PSA (median ± SE) | 15.8 ± 4.8 | 12.1 ± 7.6 | 13.1 ± 5.3 | 0.31 | ||||
NOTE: Column percentages may sum to >100% due to rounding.